Medifast, Inc. (LON:0K05)
London
· Delayed Price · Currency is GBP · Price in USD 14.60
+0.36 (2.54%)
At close: Feb 21, 2025
Medifast Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 602.46 | 1,072 | 1,599 | 1,526 | 934.84 | Upgrade
|
| Revenue Growth (YoY) | -43.80% | -32.94% | 4.75% | 63.25% | 30.99% | Upgrade
|
| Cost of Revenue | 157.84 | 296.2 | 458.16 | 398.49 | 237.03 | Upgrade
|
| Gross Profit | 444.62 | 775.85 | 1,140 | 1,128 | 697.82 | Upgrade
|
| Selling, General & Admin | 424.64 | 644.85 | 951.11 | 906.96 | 560.86 | Upgrade
|
| Research & Development | 4.6 | 4.6 | 4.5 | 4.4 | 2.8 | Upgrade
|
| Operating Expenses | 429.24 | 649.45 | 955.61 | 911.36 | 563.66 | Upgrade
|
| Operating Income | 15.38 | 126.4 | 184.81 | 216.24 | 134.16 | Upgrade
|
| Interest Expense | - | - | -0.7 | -0.23 | - | Upgrade
|
| Interest & Investment Income | 4.8 | 2.49 | - | - | 0.25 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.9 | -0.1 | -0.05 | 0.12 | -0.14 | Upgrade
|
| EBT Excluding Unusual Items | 16.29 | 128.8 | 184.06 | 216.13 | 134.27 | Upgrade
|
| Asset Writedown | -11.69 | - | - | - | - | Upgrade
|
| Other Unusual Items | -0.81 | - | - | - | - | Upgrade
|
| Pretax Income | 3.79 | 128.8 | 184.06 | 216.13 | 134.27 | Upgrade
|
| Income Tax Expense | 1.7 | 29.38 | 40.49 | 52.1 | 31.41 | Upgrade
|
| Earnings From Continuing Operations | 2.09 | 99.42 | 143.57 | 164.03 | 102.86 | Upgrade
|
| Net Income | 2.09 | 99.42 | 143.57 | 164.03 | 102.86 | Upgrade
|
| Net Income to Common | 2.09 | 99.42 | 143.57 | 164.03 | 102.86 | Upgrade
|
| Net Income Growth | -97.90% | -30.75% | -12.48% | 59.47% | 32.01% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 12 | 12 | Upgrade
|
| Shares Change (YoY) | 0.38% | -3.15% | -4.55% | -0.31% | -2.20% | Upgrade
|
| EPS (Basic) | 0.19 | 9.13 | 12.82 | 14.01 | 8.74 | Upgrade
|
| EPS (Diluted) | 0.19 | 9.10 | 12.73 | 13.89 | 8.68 | Upgrade
|
| EPS Growth | -97.91% | -28.52% | -8.35% | 60.02% | 34.99% | Upgrade
|
| Free Cash Flow | 17.02 | 141.17 | 177.89 | 60.34 | 139.31 | Upgrade
|
| Free Cash Flow Per Share | 1.55 | 12.93 | 15.78 | 5.11 | 11.76 | Upgrade
|
| Dividend Per Share | - | 4.950 | 6.560 | 5.680 | 4.520 | Upgrade
|
| Dividend Growth | - | -24.54% | 15.49% | 25.66% | 33.73% | Upgrade
|
| Gross Margin | 73.80% | 72.37% | 71.34% | 73.89% | 74.65% | Upgrade
|
| Operating Margin | 2.55% | 11.79% | 11.56% | 14.17% | 14.35% | Upgrade
|
| Profit Margin | 0.35% | 9.27% | 8.98% | 10.75% | 11.00% | Upgrade
|
| Free Cash Flow Margin | 2.83% | 13.17% | 11.13% | 3.95% | 14.90% | Upgrade
|
| EBITDA | 18.9 | 139.51 | 195.79 | 223.05 | 138.48 | Upgrade
|
| EBITDA Margin | 3.14% | 13.01% | 12.25% | 14.62% | 14.81% | Upgrade
|
| D&A For EBITDA | 3.52 | 13.11 | 10.98 | 6.81 | 4.32 | Upgrade
|
| EBIT | 15.38 | 126.4 | 184.81 | 216.24 | 134.16 | Upgrade
|
| EBIT Margin | 2.55% | 11.79% | 11.56% | 14.17% | 14.35% | Upgrade
|
| Effective Tax Rate | 44.78% | 22.81% | 22.00% | 24.11% | 23.39% | Upgrade
|
| Advertising Expenses | 14.1 | 3.4 | 1.7 | 1.6 | 4.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.